May 4, 2023: Moderna revenues down, Regeneron up in Q1

Moderna’s revenues fall and Regeneron’s rise within the first quarter
Roche opens a brand new institute to advance analysis in human mannequin methods
ImmunoGen Studies Optimistic First-Line Knowledge From Ovarian Most cancers Remedy Trial
FDA approves first RSV vaccine, licenses GSK’s Arexvy for older adults
*Please scroll down for the newest information*

#Moderna #revenues #Regeneron

Leave a Reply

Your email address will not be published. Required fields are marked *